References
- Chen, H.F., Chen, Y.Q., Orr, B.G., Holl, M.B., Majoros, I., Clarkson, B.H. (2004). Nanoscale probing of the enamel nanorod surface using polyamidoamine dendrimers. Langmuir, 20, 4168–71.
- Cheng, Y.Y., Xu, T.W. (2008). The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs. Eur J Med Chem, 43, 2291–7.
- Crespo, L., Sanclimens, G., Pons, M., Giralt, E., Royo, M., Albericio, F. (2005). Peptide and amide bond-containing dendrimers. Chem Rev, 105, 1663–81.
- Erez, R., Ebner, S., Attali, B., Shabat, D. (2008). Chemotherapeutic bone-targeted bisphosphonate prodrugs with hydrolytic mode of activation. Bioorg Med Chem Lett, 18, 816–20.
- He, G., Guo, L. (2008). Progress in dendrimers as drug carriers. Chin J Org Chem, 28, 1326–35.
- Hengst, V., Oussoren, C., Kissel, T., Storm, G. (2007). Bone targeting potential of bisphosphonate-targeted liposomes— preparation, characterization and hydroxyapatite binding in vitro. Int J Pharm, 331, 224–7.
- Hirabayashi, H., Takahashi, T., Fujisaki, J., Masunaga, T., Sato, S., Hiroi, J., Tokunaga, Y., Kimura, S., Hata, T. (2001). Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS). J Contr Rel, 70, 183–91.
- Ishizaki, J., Waki, Y., Takahashi-Nishioka, T., Yokogawa, K., Miyamoto, K. (2009). Selective drug delivery to bone using acidic oligopeptides. J Bone Miner Metab, 27, 1–8.
- Kono, K., Liu, M.J., Frechet, JMJ. (1999). Design of dendritic macromolecules containing folate or methotrexate residues. Bioconjugate Chem, 10, 1115–21.
- Murphy, M.B., Hartgerink, J.D., Goepferich, A., Mikos, A.G. (2007). Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties. Biomacromolecules, 8, 2237–43.
- Najlah, M., Freeman, S., Attwood, D., D’Emanuele, A. (2006). Synthesis, characterization and stability of dendrimer prodrugs. Int J Pharm, 308, 175–82.
- Otvos, L. (2008). Peptide-based drug design. New York: Springer Science.
- Sarig, S. (2004). Aspartic acid nucleates the apatite crystallites of bone: a hypothesis. Bone, 35, 108–13.
- Singh, M. (2008). Simultaneous study of interfacial tension, surface tension, and viscosity of few surfactant solutions with survismeter. Surf Interface Anal, 40, 1344–9.
- Svenson, S., Chauhan, A.S. (2008). Dendrimers for enhanced drug solubilization. Nanomedicine, 3, 679–702.
- Tang, X.Y., Zhang, P., Ye, H., Zhang, C., Shen, W.B., Ping, Q.N. (2008). Water-soluble gambogic acid PEGylated prodrugs: synthesis, characterization, physicochemical properties and in vitro hydrolysis. Pharmazie, 63, 711–7.
- Villalonga-Barber, C., Micha-Screttas, M., Steele, B.R., Georgopoulos, A., Demetzos, C. (2008). Dendrimers as biopharmaceuticals: synthesis and properties. Curr Top Med Chem, 8, 1294–309.
- Wang, D., Miller, S., Sima, M., Kopeckova, P., Kopecek, J. (2003). Synthesis and evaluation of water-soluble polymeric bone- targeted drug delivery systems. Bioconjugate Chem, 14, 853–9.
- Wang, D., Miller, S.C., Kopeckova, P., Kopecek, J. (2005). Bone-targeting macromolecular therapeutics. Adv Drug Deliv Rev, 57, 1049–76.